Programmed death ligand 1 (PD-L1) as an immunotherapy target in patients with glioblastoma.
Journal Article (Editorial)
Full Text
Duke Authors
Cited Authors
- Vlahovic, G; Fecci, PE; Reardon, D; Sampson, JH
Published Date
- August 2015
Published In
Volume / Issue
- 17 / 8
Start / End Page
- 1043 - 1045
PubMed ID
- 25964311
Pubmed Central ID
- PMC4490880
Electronic International Standard Serial Number (EISSN)
- 1523-5866
Digital Object Identifier (DOI)
- 10.1093/neuonc/nov071
Language
- eng
Conference Location
- England